Integrating anamnestic and lifestyle data with sphingolipid levels for risk-based prostate cancer screening.

Peraldo-Neia C, Ostano P, Savioli M, Mello-Grand M, Gregnanin I, Guana F, Crivelli F, Montagnani F, Dei-Cas M, Paroni R, Sinopoli A, Ferranti F, Testino N, Oderda M, Zitella A, Fiameni C, Gagliardi A, Naccarati A, Clivio L, Gontero P, Zaramella S, Chiorino G

Open source

DOI: 10.1186/s12967-025-06820-9
Published: 2025 Jul 14
Container: Journal of translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12967-025-06820-9,
  title = {Integrating anamnestic and lifestyle data with sphingolipid levels for risk-based prostate cancer screening.},
  author = {Peraldo-Neia C and Ostano P and Savioli M and Mello-Grand M and Gregnanin I and Guana F and Crivelli F and Montagnani F and Dei-Cas M and Paroni R and Sinopoli A and Ferranti F and Testino N and Oderda M and Zitella A and Fiameni C and Gagliardi A and Naccarati A and Clivio L and Gontero P and Zaramella S and Chiorino G},
  year = {2025},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-025-06820-9},
  url = {https://doi.org/10.1186/s12967-025-06820-9}
}

RIS

TY  - JOUR
TI  - Integrating anamnestic and lifestyle data with sphingolipid levels for risk-based prostate cancer screening.
AU  - Peraldo-Neia C
AU  - Ostano P
AU  - Savioli M
AU  - Mello-Grand M
AU  - Gregnanin I
AU  - Guana F
AU  - Crivelli F
AU  - Montagnani F
AU  - Dei-Cas M
AU  - Paroni R
AU  - Sinopoli A
AU  - Ferranti F
AU  - Testino N
AU  - Oderda M
AU  - Zitella A
AU  - Fiameni C
AU  - Gagliardi A
AU  - Naccarati A
AU  - Clivio L
AU  - Gontero P
AU  - Zaramella S
AU  - Chiorino G
PY  - 2025
JO  - Journal of translational medicine
DO  - 10.1186/s12967-025-06820-9
UR  - https://doi.org/10.1186/s12967-025-06820-9
ER  -

APA

C, P., P, O., M, S., M, M., I, G., F, G., F, C., F, M., M, D., R, P., A, S., F, F., N, T., M, O., A, Z., C, F., A, G., A, N., L, C., P, G., S, Z., & G, C. (2025). Integrating anamnestic and lifestyle data with sphingolipid levels for risk-based prostate cancer screening.. Journal of translational medicine. https://doi.org/10.1186/s12967-025-06820-9

Source records

pubmed · retrieved 2026-09-26T22:10:08.809Z